SCHEMBL4801334

SCHEMBL4801334

C=CC[S+]([O-])S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9717355 0.73
SCHEMBL3676210 0.72
SCHEMBL9635 0.72
SCHEMBL16201955 0.69
SCHEMBL4329032 0.69
SCHEMBL4329029 0.69
SCHEMBL20817064 0.69
Ammonia Solution, Strong SCHEMBL10454832 0.69
SCHEMBL9774990 0.67
SCHEMBL3302971 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230285493-A1 ANTIMICROBIAL COMPOSITION MOOTRAL SA (CH) 2023-09-14 US disclosed
EP-3236978-B1 AN ANTIMICROBIAL COMPOSITION MOOTRAL SA (CH) 2023-06-14 EP disclosed
US-20220370398-A1 METHOD TO DESTABALIZE CYSTEINE EXPOSED INFECTIOUS INFORMATION VECTORS PEREZ JOHN SCOTT (US) 2022-11-24 US disclosed
US-20170071839-A1 Personal care and medicinal products incorporating organosulfur groups OTT DAVID MICHAEL (US) 2017-03-16 US disclosed
WO-2016109701-A1 ENHANCED MODULAR ELECTRONIC CIGARETTE ASSEMBLY WITH DISPOSABLE ELEMENTS INCLUDING TANKS VOODOO SCIENCE LLC (US) 2016-07-07 WO disclosed
US-9226885-B2 Personal care and medicinal products incorporating bound organosulfur groups ALLIUM VITALIS INCORPORATED (US) 2016-01-05 US disclosed
US-20140349969-A1 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES AG (AT) 2014-11-27 US disclosed
US-20140050677-A1 Personal care and medicinal products incorporating bound organosulfur groups OTT DAVID MICHAEL (US) 2014-02-20 US disclosed
EP-2674161-A1 FMO3 inhibitors for treating pain Akron Molecules GmbH (AT) 2013-12-18 EP disclosed
US-20130252924-A1 Compounds and Methods for Treating Pain AKRON MOLECULES GMBH (AT) 2013-09-26 US disclosed
US-20050176009-A1 Nucleotide sequences coding orphan receptors for identifying modulators of smell reception; enhancing odor detection; perfumes YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2005-08-11 US disclosed
WO-2002004413-A9 CHIRAL INTEGRIN MODULATORS AND METHODS OF USE THEREOF DAVIDSON JOHN B (US) 2004-05-06 WO disclosed
US-20040053892-A1 Chiral integrin modulators and methods of use thereof BILLINGS PHARMACEUTICALS, INC. 2004-03-18 US disclosed
EP-1309548-A1 CHIRAL INTEGRIN MODULATORS AND METHODS OF USE THEREOF Billings Pharmaceuticals, Inc. (US) 2003-05-14 EP disclosed
EP-1230259-A1 S-ALLYLMERCAPTOGLUTATHIONE AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) 2002-08-14 EP disclosed
WO-2002004413-A1 CHIRAL INTEGRIN MODULATORS AND METHODS OF USE THEREOF DAVIDSON JOHN B (US) 2002-01-17 WO disclosed
WO-2001036450-A1 S-ALLYLMERCAPTOGLUTATHIONE AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2001-05-25 WO disclosed
US-5321045-A PAF-induced bronchial obstructions BOEHRINGER MANNHEIM GMBH (DE) 1994-06-14 US disclosed
US-4665088-A ANTICOAGULANTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1987-05-12 US disclosed
US-4665088-A ANTICOAGULANTS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1987-05-12 US disclosed